Article
National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.
Practice What You Preach: A Clinician's Guide to Chemical Peels
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Four Key Factors When Buying Dermatology Devices
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
The Future of Body Contouring: Insights from David Goldberg, MD, JD
Phase 3b Data Reinforce Rapid, Long-Lasting Efficacy of RelabotulinumtoxinA for Glabellar Lines